Shengzhe Lin
Key Laboratory Of Gastrointestinal Cancer
Fuzhou, 350122, China
Fuzhou, 350122, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Bacterial outer membrane vesicles OMV-LL for delivery of neoantigen mRNA to induce anti-HCC therapy.
Bacterial outer membrane vesicles OMV-LL for delivery of neoantigen mRNA to induce anti-HCC therapy.
Journal: Frontiers in immunology
Published: May 22, 2025
Annexin A1 mRNA-loaded liposomes alleviate acute pancreatitis by suppressing STING pathway and promoting efferocytosis in macrophages.
Journal: Nature nanotechnology
Published: August 06, 2024
BCL2A1 neoepitope-elicited cytotoxic T lymphocytes are a promising individualized immunotherapy of pancreatic cancer.
Journal: Journal of leukocyte biology
Published: October 27, 2023
Predictive indicators of immune therapy efficacy in hepatocellular carcinoma based on neutrophil-to-lymphocyte ratio.
Journal: International immunopharmacology
Published: October 22, 2023
Does Using Indocyanine Green Fluorescence Imaging for Tumors Help in Determining the Safe Surgical Margin in Real-Time Navigation of Laparoscopic Hepatectomy? A Retrospective Study.
Journal: Annals of surgical oncology
Published: August 31, 2022
Altered HLA-A2-restricted TP53 epitope induces specific CTL cytotoxicity against hepatocellular carcinoma.
Journal: European journal of immunology
Published: June 29, 2022
Altered MUC1 epitope-specific CTLs: A potential target for immunotherapy of pancreatic cancer.
Journal: Journal of leukocyte biology
Published: February 25, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026